Document Detail


Current and future imaging modalities for multiple myeloma and its precursor states.
MedLine Citation:
PMID:  21649546     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Traditionally, the skeletal survey has been the standard modality for the detection of osteolytic bone disease in multiple myeloma. In addition to its poor sensitivity for the detection of osteolytic lesions, this modality is not able to identify extramedullary lesions and focal bone marrow involvement, nor measure response to therapy. The application of novel imaging techniques such as computed tomography (CT), magnetic resonance imaging (MRI), and molecular imaging such as fluorine-18 fluorodeoxyglucose positron emission tomography CT ((18)F-FDG PET/CT) and fluorine-18 sodium fluoride positron emission tomography CT ((18)F-NaF PET/CT) has the potential to overcome these limitations as well as provide prognostic information in precursor states and multiple myeloma. Also promising is the use of dynamic contrast enhanced magnetic resonance imaging (DCE MRI) to measure vascular permeability, an important feature of myelomagenesis. This review summarizes the current status and possible future role of novel imaging modalities in multiple myeloma and its precursor states.
Authors:
Esther Tan; Brendan M Weiss; Esther Mena; Neha Korde; Peter L Choyke; Ola Landgren
Related Documents :
12655266 - Magnetic resonance imaging and magnetic resonance cholangiopancreaticography for diagno...
12118956 - Endoscopic retrograde cholangiopancreatography should no longer be used as a diagnostic...
17466206 - Eus with ct improves efficiency and structure identification over conventional eus.
15333766 - Differentiation of extrahepatic bile duct cholangiocarcinoma from benign stricture: fin...
7457326 - The ultrasonically enhanced abdominal examination.
9530036 - Variability in the detection of enlarged mediastinal lymph nodes in staging lung cancer...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-6-8
Journal Detail:
Title:  Leukemia & lymphoma     Volume:  -     ISSN:  1029-2403     ISO Abbreviation:  -     Publication Date:  2011 Jun 
Date Detail:
Created Date:  2011-6-8     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9007422     Medline TA:  Leuk Lymphoma     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Multiple Myeloma Section, Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda , MD , USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Keratinocyte growth factor enhanced immune reconstitution in murine allogeneic umbilical cord blood ...
Next Document:  miRNA expression profiles in myelodysplastic syndromes reveal Epstein-Barr virus miR-BART13 dysregul...